Keyword [antitumor agents]
Result: 21 - 40 | Page: 2 of 3 |
| 21. | Design, Synthesis And Biological Evaluation Of MDM2 Ubiquitin Ligase Inhibitors As Antitumor Agents |
| 22. | Design, Synthesis, Biological Evaluation And SAR Studies Of Sorafenib Derivatives As Potential Antitumor Agents |
| 23. | Novel Water-soluble Photosensitizers As Antitumor Agents For Photodynamic Therapy |
| 24. | Studies Of Antitumor Iridium Hydrides Complexes And The Evolution Of Sortase A, Protein Modification With Unnatural Amino Acids |
| 25. | The Antiplatelet And Antithrombotic Effects Of DMXAA And The Mechanism Of NOD2 Potentiating Platelet Activation And Thrombosis |
| 26. | The Reseach On The LAT1-targeting Antitumor Agents And Its Pharmacokenetics |
| 27. | Structural Modification Of Camptothecin As Antitumor Agents |
| 28. | The Study Of Novel Antitumor Drugs And Corresponding Diagnostic Fluorescence Probe |
| 29. | Mechanisms Of Resistance To Antitumor Agents Targeting PI3K |
| 30. | Synthesis Of Podophyllotoxin Derivatives As Antitumor Agents |
| 31. | Synthesis, Biological Evaluation And Molecular Docking Studies Of 1,3,4-oxadiazole Derivatives As Potential Antitumor Agents |
| 32. | Novel 4-(4-substituted Amidobenzyl) Furan-2-(5H)-one Derivatives As Antitumor Agents Based On Topoisomerase Ⅰ Target |
| 33. | Functional Properties Of The Novel Antitumor Agents:NS,TAT-camptothecin Conjugates TAT-CPT/2CPT And[Cys-CPT2,9]penetratin In Antitumor Applications |
| 34. | Design,Synthesis And Biological Evaluation Of Multi-targeting Antitumor Agents And Proteolysis Targeting Chimera |
| 35. | Design,synthesis And Biological Evaluation Of Tubulin Inhibitors As Antitumor Agents Targeting The Colchicine Binding Site |
| 36. | Synthesis And Biological Evaluation Of Novel 7-hydroxy-4-phenylchromen-2-one-linked To Triazole Moieties As Potent Antitumor Agents |
| 37. | Design,Synthesis And Mechanisms Of Action Of Novel Harmine Derivatives As Potential Antitumor Agents |
| 38. | Design,Preparation And Activities Of New Dual-targeted Platinum Antitumor Agents |
| 39. | Design,Synthesis And Bioactivity Evaluation Of Antitumor Agents Targeting BRAF Kinase |
| 40. | Structure--activity relationship studies of hybrid antitumor agents for the treatment of non-small cell lung cancer |
|
